NCT02917239View on ClinicalTrials.gov

Prevalence of Ocular Disorders in Multiple Myeloma (MM-OO-16)

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

Multiple Myeloma

All Listed Sponsors

lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER

NCT02917239 - Prevalence of Ocular Disorders in Multiple Myeloma (MM-OO-16) | Biotech Hunter | Biotech Hunter